Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy
New Delhi: Novavax, Inc.today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe ...
Tag: PREVENT-19 pivotal Phase 3 trial